Regeneron Pharmaceuticals REGN Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Regeneron Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regeneron Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regeneron Pharmaceuticals's prepaid & other current?
- Regeneron Pharmaceuticals (REGN) reported prepaid & other current of $620.9M in Q1 2026.
- How has Regeneron Pharmaceuticals's prepaid & other current changed year-over-year?
- Regeneron Pharmaceuticals's prepaid & other current increased by 32.4% year-over-year, from $468.9M to $620.9M.
- What is the long-term trend for Regeneron Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's prepaid & other current has grown at a 24.2% compound annual growth rate (CAGR), from $160.8M to $474.8M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.